🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-525619-15-00
Completed Phase I

A study to assess the safety, and blood levels of CTX-187 after single and repeated intravenous doses in healthy volunteers and patients with bacterial infection

2026-525619-15-00 · tracked via the Priya Life Science EU tracker
Sponsor
Centauri Therapeutics Limited
Sponsor type
Pharmaceutical company
Therapeutic area
Bacterial Infections and Mycoses
Decision date
30/04/2026
Enrollment target
68
Sites
Netherlands

Condition studied

Bacterial Infection

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525619-15-00 on CTIS ↗ ← All trials in the EU